PITRESSIN Side Effects

6818700-2 | Acidosis, Airway Peak Pressure Increased, Anuria, Cardiac Arrest, Loss Of Consciousness, Low Cardiac Output Syndrome, Mean Arterial Pressure Decreased, Muscle Rigidity, No Therapeutic Response
on Jun 23, 2010 Female patient from INDIA , 35 years of age, weighting 92.59 lb, was diagnosed with vasoconstriction, muscle disorder (What is muscle disorder?) and was treated with Pitressin (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, airway peak pressure increased, anuria, cardiac arrest (What is cardiac arrest?), loss of consciousness, low cardiac output syndrome, mean arterial pressure decreased, muscle rigidity, no therapeutic response. Pitressin dosage: 6 U/hr, Intravenous. During the same period patient was treated with EPINEPHRINE (0.05 Ug/kg, Min, Intravenous) (View Epinephrine Review and Epinephrine Label ), DOPAMINE HCL (10 Ug/kg, Min, Intravenous) (View Dopamine Hcl Review and Dopamine Hcl Label ), NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) (0.05 Ug/kg, Min, Intravenous ) (View Norepinephrine (norepinephrine Bitartrate) Review and Norepinephrine (norepinephrine Bitartrate) Label ), DOBUTAMINE HCL (5 Ug/kg, Min, Intravenous) (View Dobutamine Hcl Review and Dobutamine Hcl Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ).

6701528-1 | Cardiac Arrest, Continuous Haemodiafiltration, Fluid Overload, Hyperkalaemia, Infection, Metabolic Acidosis, Pneumonia, Renal Failure Acute
Patient was taking Pitressin (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), continuous haemodiafiltration, fluid overload, hyperkalaemia, infection (What is infection?), metabolic acidosis, pneumonia (What is pneumonia?), renal failure acute on Apr 21, 2010 from UNITED STATES Additional patient health information: Male patient , 56 years of age, weighting 429.9 lb, was diagnosed with haemodynamic instability, hypotension and. Pitressin dosage: 0.04 U/min On And Off For 47 Days, Intravenous. During the same period patient was treated with NOREPINEPHRINE (NOREPINEPHRINE BILARTRATE) (70 Ug/min, Intravenous; 40 Ug/min, Intravenous) (View Norepinephrine (norepinephrine Bilartrate) Review and Norepinephrine (norepinephrine Bilartrate) Label ), PHENYLEPHRINE (PHENYLEPHRINE HYDROCHLORIDE) (200 Ug/min, Intravenous) (View Phenylephrine (phenylephrine Hydrochloride) Review and Phenylephrine (phenylephrine Hydrochloride) Label ), HYDROCORTISONE (HYDROCORTISONE HYDROGEN SUCCINATE) (100 Mg, Tid, Intravenous) (View Hydrocortisone (hydrocortisone Hydrogen Succinate) Review and Hydrocortisone (hydrocortisone Hydrogen Succinate) Label ), COLISTIMETHATE SODIUM (COLISTIN MESILATE SODIUM) (View Colistimethate Sodium (colistin Mesilate Sodium) Review and Colistimethate Sodium (colistin Mesilate Sodium) Label ), AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CASPOFUNGIN (CASPOFUNGIN) (View Caspofungin (caspofungin) Review and Caspofungin (caspofungin) Label ).

6692960-3 | Continuous Haemodiafiltration, Fluid Overload, Metabolic Acidosis, Pneumonia, Renal Failure Acute, Respiratory Failure, Septic Shock
Adverse event was reported on Apr 05, 2010 by a Male patient taking Pitressin (View Usage) (Dosage: 0.04 U/min On And Off For 47 Days, Intravenous) was diagnosed with haemodynamic instability, hypotension and. Location: UNITED STATES , 56 years of age, weighting 429.9 lb, After Pitressin was administered, patient had the following side effects: continuous haemodiafiltration, fluid overload, metabolic acidosis, pneumonia (What is pneumonia?), renal failure acute, respiratory failure, septic shock. During the same period patient was treated with NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) (70 Ug/min, Intravenous) (View Norepinephrine (norepinephrine Bitartrate) Review and Norepinephrine (norepinephrine Bitartrate) Label ), PHENYLEPHRINE (PHENYLEPHRINE HYDROCHLORIDE) (200 Ug/min, Intravenous) (View Phenylephrine (phenylephrine Hydrochloride) Review and Phenylephrine (phenylephrine Hydrochloride) Label ), HYDROCORTISONE (HYDROCORTISONE HYDROGEN SUCCINATE) (100 Mg, Tid, Intravenous) (View Hydrocortisone (hydrocortisone Hydrogen Succinate) Review and Hydrocortisone (hydrocortisone Hydrogen Succinate) Label ), COLISTIMETHATE SODIUM (COLISTIN MESILATE SODIUM) (View Colistimethate Sodium (colistin Mesilate Sodium) Review and Colistimethate Sodium (colistin Mesilate Sodium) Label ), AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CASPOFUNGIN (CASPOFUNGIN) (View Caspofungin (caspofungin) Review and Caspofungin (caspofungin) Label ).

6691399-4 | Grand Mal Convulsion, Hypertension, Off Label Use, Pallor, Pulmonary Oedema, Radial Pulse Abnormal, Sinus Bradycardia, Tachycardia, Unresponsive To Stimuli
on Apr 01, 2010 Female patient from INDIA , 34 years of age, weighting 99.21 lb, was diagnosed with haemostasis and was treated with Pitressin (View Usage). Patient experienced the following unwanted or unexpected effects: grand mal convulsion, hypertension, off label use, pallor, pulmonary oedema, radial pulse abnormal, sinus bradycardia, tachycardia, unresponsive to stimuli. Pitressin dosage: 20 Ml Of 1u/ml Intramyometrially. During the same period patient was treated with BUPIVACAINE HCL (View Bupivacaine Hcl Review and Bupivacaine Hcl Label ), BUPRENORPHINE (BUPRENORPHINE) (View Buprenorphine (buprenorphine) Review and Buprenorphine (buprenorphine) Label ), LACTATE RINGER (CALCIUM CHLORIDE ANHYDROUS, POTASSIUM CHLORIDE, SODIUM (View Lactate Ringer (calcium Chloride Anhydrous, Potassium Chloride, Sodium Review and Lactate Ringer (calcium Chloride Anhydrous, Potassium Chloride, Sodium Label ).


6455196-7 | Cardiogenic Shock, Post Procedural Haemorrhage, Respiratory Failure
on Nov 03, 2009 Female patient from UNITED STATES , 86 years of age, weighting 102.7 lb, was diagnosed with hypotension, myocardial reperfusion injury and was treated with Pitressin (View Usage). Patient had the following side effects: cardiogenic shock, post procedural haemorrhage, respiratory failure. Pitressin dosage: 0.04 Units, Qh, Intravenous. During the same period patient was treated with CARDIOPLEGIA (MAGNESIUM CHLOIRDE ANHYDROUS, POTASSIUM CHLORIDE, PROCAI (View Cardioplegia (magnesium Chloirde Anhydrous, Potassium Chloride, Procai Review and Cardioplegia (magnesium Chloirde Anhydrous, Potassium Chloride, Procai Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), FUROSEMIDE (FUROSEMDIE SODIUM) (View Furosemide (furosemdie Sodium) Review and Furosemide (furosemdie Sodium) Label ), MAGNESIUM (MAGNESIUM HYDROXIDE) (View Magnesium (magnesium Hydroxide) Review and Magnesium (magnesium Hydroxide) Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

6313254-1 | Cardiac Arrest, Electrocardiogram St Segment Abnormal, Off Label Use, Pulmonary Vascular Disorder, Sinus Bradycardia
Patient was taking Pitressin (View Usage). After Pitressin was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), electrocardiogram st segment abnormal, off label use, pulmonary vascular disorder, sinus bradycardia on Aug 03, 2009 from JAPAN Additional patient health information: Female patient , weighting 110.2 lb, was diagnosed with haemostasis and. Pitressin dosage: Total Of 11 Units (0.2 Units/ml) Intramyometrically.

6100098-9 | Blood Pressure Increased, Electrocardiogram St Segment Depression, Heart Rate Decreased, Heart Rate Increased, Hypotension, Ventricular Extrasystoles
Adverse event was reported on Feb 17, 2009 by a Female patient taking Pitressin (View Usage) (Dosage: 6 Units- Intramyhometrial Injection (30ml Of 0.2 U/ml Dilution), Intramuscular) was diagnosed with haemostasis, anaesthesia and. Location: JAPAN , 30 years of age, weighting 127.9 lb, Patient experienced the following unwanted or unexpected effects: blood pressure increased, electrocardiogram st segment depression, heart rate decreased, heart rate increased, hypotension, ventricular extrasystoles. During the same period patient was treated with THIOPENTAL SODIUM (250 Mg, Intravenous) (View Thiopental Sodium Review and Thiopental Sodium Label ), VECURONIUM BROMIDE (8 Mg, Intravenous) (View Vecuronium Bromide Review and Vecuronium Bromide Label ), SEVOFLURANE (1% Concentration, Inhalation) (View Sevoflurane Review and Sevoflurane Label ), NITROUS OXIDE W/ OXYGEN (4 L/min, Inhalation) (View Nitrous Oxide W/ Oxygen Review and Nitrous Oxide W/ Oxygen Label ), MIDAZOLAM HCL (2.5 Mg, Intramuscular) (View Midazolam Hcl Review and Midazolam Hcl Label ), MEPIVACAINE (MEPIVACAINE) 1% (5 Ml, Epidural) (View Mepivacaine (mepivacaine) 1% Review and Mepivacaine (mepivacaine) 1% Label ), FENTANYL 100 (0.1 Mg, Epidural) (View Fentanyl-100 Review and Fentanyl-100 Label ).

6088245-9 | Blood Pressure Increased, Electrocardiogram St Segment Depression, Heart Rate Decreased, Heart Rate Increased, Hypotension, Ventricular Extrasystoles
on Feb 09, 2009 Female patient from JAPAN , 30 years of age, was treated with Pitressin (View Usage). Patient had the following side effects: blood pressure increased, electrocardiogram st segment depression, heart rate decreased, heart rate increased, hypotension, ventricular extrasystoles. Pitressin dosage: Intramyometrial Injection, Intramuscular. During the same period patient was treated with THIOPENTAL SODIUM (250 Mg, Intravenous) (View Thiopental Sodium Review and Thiopental Sodium Label ), VECURONIUM BROMIDE (8 Mg, Intravenous) (View Vecuronium Bromide Review and Vecuronium Bromide Label ), SEVOFLURANE (Inhalation) (View Sevoflurane Review and Sevoflurane Label ), NITROUS OXIDE W/ OXYGEN (Inhalation) (View Nitrous Oxide W/ Oxygen Review and Nitrous Oxide W/ Oxygen Label ).

4836165-7 | Diabetes Insipidus, Hypernatraemia, Iatrogenic Injury, Polyuria
on Nov 13, 2005 Male patient from UNITED STATES , 34 years of age, was diagnosed with hypotension, fungal skin infection and was treated with Pitressin (View Usage). After Pitressin was administered, patient had the following side effects: diabetes insipidus (What is diabetes insipidus?), hypernatraemia, iatrogenic injury, polyuria. Pitressin dosage: . During the same period patient was treated with NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ), ANTIFUNGALS (View Antifungals Review and Antifungals Label ). Patient was hospitalized.

4776953-9 | Atrial Bigeminy, Atrioventricular Block, Blood Pressure Decreased, Blood Pressure Immeasurable, Bradycardia, Extrasystoles, Haemorrhage, Heart Rate Decreased, Hypertension
Patient was taking Pitressin (View Usage). Patient experienced the following unwanted or unexpected effects: atrial bigeminy, atrioventricular block, blood pressure decreased, blood pressure immeasurable, bradycardia, extrasystoles, haemorrhage, heart rate decreased, hypertension on Sep 13, 2005 from CANADA Additional patient health information: Female patient , 31 years of age, was diagnosed with myomectomy, epidural anaesthesia, maintenance of anaesthesia, hypotension and. Pitressin dosage: 3 U Of .5 U/ml, Unk. During the same period patient was treated with BUPIVACAINE (5 Mg, Unk) (View Bupivacaine Review and Bupivacaine Label ), SUFENTANIL CITRATE (25 Ug, Unk) (View Sufentanil Citrate Review and Sufentanil Citrate Label ), MORPHINE (.25 Mg, Unk) (View Morphine Review and Morphine Label ), PROPOFOL (2 Mg/kg, Unk) (View Propofol Review and Propofol Label ), DESFLURANE (.6 Mac, Unk) (View Desflurane Review and Desflurane Label ), PHENYLEPHRINE (PHENYLEPHRINE) (.1 Mg, 5 Doses) (View Phenylephrine (phenylephrine) Review and Phenylephrine (phenylephrine) Label ). Patient was hospitalized.